Medicare Enrolled

Dr. Andrzej Jasek, MD

Rheumatology · Rockford, IL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
5875 E RIVERSIDE BLVD, Rockford, IL 61114
8153989491
In practice since 2006 (19 years)
NPI: 1578636692 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Jasek from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jasek? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Jasek

Dr. Andrzej Jasek is a rheumatology specialist in Rockford, IL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Jasek performed 129,737 Medicare services across 2,109 unique beneficiaries.

Between the years covered by Open Payments, Dr. Jasek received a total of $3,158 from 17 pharmaceutical and/or device companies across 174 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Jasek is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 6% volume in IL $3,158 industry payments

Medicare Practice Summary

Medicare Utilization ↗
129,737
Medicare services
Top 6% in IL for rheumatology
2,109
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~6,828 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Tocilizumab injection (Actemra) 65,680 $5 $25
Golimumab infusion (Simponi Aria)
Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery.
14,450 $10 $73
Denosumab injection (Prolia/Xgeva) 12,420 $18 $91
Romosozumab injection (Evenity) for osteoporosis 11,130 $8 $40
Abatacept infusion (Orencia)
An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered.
10,200 $34 $173
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
4,970 $26 $258
Rituximab injection, 10 mg
Administration of a 10 mg dose of rituximab medication via injection.
2,750 $61 $330
Joint lubricant injection (Synvisc) 1,872 $7 $41
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
1,575 $1 $21
Joint lubricant injection (TriVisc)
An injection of hyaluronan or a derivative into a joint space. The dose specified is 1 milligram.
1,452 $7 $42
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
701 $85 $318
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
458 $11 $62
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
286 $94 $595
Ultrasound-guided large joint aspiration or injection
This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint.
278 $82 $521
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
261 $47 $293
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
240 $56 $215
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
230 $7 $180
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
116 $11 $74
Bone density scan (DEXA) of hip, pelvis, and spine
This test measures bone density in the hip, pelvis, and spine to assess bone strength. It also includes an assessment for spine fractures.
95 $48 $218
Ketorolac injection, per 15 mg
An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg.
92 $0 $25
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
60 $19 $126
Methylprednisolone injection, up to 125 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg.
57 $4 $23
Injection, hydrocortisone sodium succinate, up to 100 mg 53 $13 $72
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
51 $106 $490
Ultrasound-guided small joint aspiration or injection
This procedure involves removing fluid from or injecting medication into a small joint while using ultrasound imaging to guide the needle placement.
41 $55 $385
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
33 $79 $320
Injection, methylprednisolone acetate, 40 mg 33 $6 $30
X-ray of hand, minimum of 3 views
An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints.
27 $45 $219
Ultrasound-guided joint aspiration or injection
Removal of fluid from or injection into a medium-sized joint using ultrasound guidance to ensure accurate placement.
25 $63 $429
Knee X-ray, 3 views
An X-ray imaging test of the knee joint that captures three different angles to evaluate the bones and surrounding structures.
22 $41 $214
X-ray of lower and sacral spine, 2-3 views
An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area.
19 $29 $174
Trigger point injection, 1-2 muscles
A procedure involving the injection of medication into one or two specific muscles to treat trigger points.
14 $36 $267
Shoulder X-ray, 2+ views
An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures.
12 $32 $176
Ultrasound guidance for needle placement
Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure.
12 $44 $588
X-ray of upper spine, 2-3 views
An X-ray imaging test of the upper spine using two to three different angles to visualize the bones and structures.
11 $22 $172
Hip X-ray, 2-3 views
An X-ray imaging test of the hip joint using two to three different angles to visualize the bones and surrounding structures.
11 $35 $204
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
23.3% high complexity
75.8% medium
0.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$3,158
Total received (2018-2024)
Avg $451/year across 7 years
Top 39% in IL for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
17
Companies
174
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,028 (95.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$90 (2.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$40 (1.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$143
2023
$178
2022
$481
2021
$254
2020
$383
2019
$1,065
2018
$654

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$79
Alexion Pharmaceuticals, Inc.
$29
Amgen Inc.
$19
GlaxoSmithKline, LLC.
$17
Top 3 companies account for 88.5% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie, Inc.
$788
Amgen Inc.
$504
ABBVIE INC.
$360
PFIZER INC.
$289
AbbVie Inc.
$260
Lilly USA, LLC
$203
Novartis Pharmaceuticals Corporation
$178
Janssen Scientific Affairs, LLC
$137
GlaxoSmithKline, LLC.
$123
UCB, Inc.
$96
AstraZeneca Pharmaceuticals LP
$79
Janssen Biotech, Inc.
$55
Alexion Pharmaceuticals, Inc.
$29
GENZYME CORPORATION
$22
SI-BONE, Inc.
$14
Radius Health, Inc.
$13
Horizon Pharma plc
$11
Top 3 companies account for 52.3% of all-time payments
Associated products mentioned in payments ›
BENLYSTA · COSENTYX · Cimzia · EVENITY · Enbrel · FORTEO · HUMIRA · Humira · KEVZARA · KRYSTEXXA · LYRICA · Otezla · REMICADE · RINVOQ · Rinvoq · SAPHNELO · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · TALTZ · TREMFYA · Tavneos · XELJANZ · iFuse Implant
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a rheumatology specialist in Rockford?
Compare rheumatologists in the Rockford area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
11
Per 100K population
3.9
County median income
$64,363
Nearest hospital
SAINT ANTHONY MEDICAL CENTER
3.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Jasek is a mixed practice specialist, with above-average Medicare volume (top 6% in IL), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Jasek experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Jasek performed 65,680 tocilizumab injection (actemra) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Jasek receive payments from pharmaceutical companies?
Yes. Dr. Jasek received a total of $3,158 from 17 companies across 174 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jasek's costs compare to other rheumatologists in Rockford?
Dr. Jasek's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jasek) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →